Literature DB >> 26141193

Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Leslie R Amodeo1, Venuz Y Greenfield, Danielle E Humphrey, Veronica Varela, Joseph A Pipkin, Shannon E Eaton, Jelesa D Johnson, Christopher P Plant, Zachary R Harmony, Li Wang, Cynthia A Crawford.   

Abstract

RATIONALE: The SSRI antidepressant fluoxetine is one of the few drugs that is effective at treating depression in adolescent humans. In contrast, the SSRI paroxetine has limited efficacy and is more at risk for inducing suicidal behavior.
OBJECTIVE: The purpose of the present study was to more fully characterize the differential actions of paroxetine and fluoxetine.
METHODS: In experiment 1, male and female rats were injected with paroxetine (2.5 or 10 mg/kg), fluoxetine (10 mg/kg), or vehicle for 10 days starting on postnatal day (PD) 35, and affective behaviors were assessed using sucrose preference and elevated plus maze tasks. A separate set of rats were used to examine monoamine levels. In experiment 2, rats were injected with paroxetine (2.5, 5, or 10 mg/kg), fluoxetine (5, 10, or 20 mg/kg), or vehicle during the same time frame as experiment 1, and anxiety-like behaviors were measured using elevated plus maze, light/dark box, and acoustic startle.
RESULTS: Repeated SSRI treatment failed to alter sucrose preference, although both paroxetine and fluoxetine reduced time spent in the open arms of the elevated plus maze and light compartment of the light/dark box. Paroxetine, but not fluoxetine, enhanced acoustic startle and interfered with habituation. Serotonin turnover was decreased by both acute and repeated fluoxetine treatment but unaltered by paroxetine administration. DISCUSSION: These results show that repeated treatment with paroxetine and fluoxetine has dissociable actions in adolescent rats. In particular, paroxetine, but not fluoxetine, increases acoustic startle at low doses and may increase sensitivity to environmental stressors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26141193      PMCID: PMC4561584          DOI: 10.1007/s00213-015-4003-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  72 in total

Review 1.  Antidepressants and body weight: a comprehensive review and meta-analysis.

Authors:  Alessandro Serretti; Laura Mandelli
Journal:  J Clin Psychiatry       Date:  2010-10       Impact factor: 4.384

2.  Startle response and anxiety sensitivity: subcortical indices of physiologic arousal and fear responding.

Authors:  Katherine A McMillan; Gordon J G Asmundson; Michael J Zvolensky; R Nicholas Carleton
Journal:  Emotion       Date:  2012-07-09

3.  Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice.

Authors:  L de Angelis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 4.  Prevalence and clinical course of depression: a review.

Authors:  Derek Richards
Journal:  Clin Psychol Rev       Date:  2011-07-23

Review 5.  Understanding the role of adjunctive nonpharmacological therapies in management of the multiple pathways to depression.

Authors:  Corina Velehorschi; Pierre Bleau; Monica Vermani; Melissa Furtado; Larry J Klassen
Journal:  Psychiatry Res       Date:  2014-12       Impact factor: 3.222

6.  MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice.

Authors:  Anne Lesemann; Claudia Reinel; Petra Hühnchen; Maximilian Pilhatsch; Rainer Hellweg; Philipp Klaissle; Christine Winter; Barbara Steiner
Journal:  Brain Res       Date:  2012-03-27       Impact factor: 3.252

7.  Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze.

Authors:  Dominique Drapier; Danièle Bentué-Ferrer; Bruno Laviolle; Bruno Millet; Hervé Allain; Michel Bourin; Jean-Michel Reymann
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

8.  Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

Authors:  Sarah Durkin; Alison Prendergast; Andrew Harkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-09-13       Impact factor: 5.067

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.

Authors:  Judith R Homberg; Jocelien D A Olivier; Tom Blom; Tim Arentsen; Chantal van Brunschot; Pieter Schipper; Gerdien Korte-Bouws; Gilles van Luijtelaar; Liesbeth Reneman
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

View more
  5 in total

1.  Adolescent fluoxetine history impairs spatial memory in adult male, but not female, C57BL/6 mice.

Authors:  Francisco J Flores-Ramirez; Lyonna F Parise; Jason B Alipio; Israel Garcia-Carachure; Samuel A Castillo; Minerva Rodriguez; Anapaula Themman; Omar Lira; Joshua Preciado-Piña; Sergio D Iñiguez
Journal:  J Affect Disord       Date:  2019-02-19       Impact factor: 4.839

Review 2.  Effects of chronic fluoxetine treatment on anxiety- and depressive-like behaviors in adolescent rodents - systematic review and meta-analysis.

Authors:  Joanna Kryst; Iwona Majcher-Maślanka; Agnieszka Chocyk
Journal:  Pharmacol Rep       Date:  2022-09-24       Impact factor: 3.919

3.  Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective.

Authors:  Sandra Ledesma-Corvi; Elena Hernández-Hernández; M Julia García-Fuster
Journal:  Transl Psychiatry       Date:  2022-06-01       Impact factor: 7.989

4.  Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats.

Authors:  Alicia Izquierdo; Hilda Pozos; Adrianna De La Torre; Simone DeShields; James Cevallos; Jonathan Rodriguez; Alexandra Stolyarova
Journal:  Behav Brain Res       Date:  2016-04-26       Impact factor: 3.332

5.  Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life.

Authors:  Francisco J Flores-Ramirez; Israel Garcia-Carachure; David O Sanchez; Celene Gonzalez; Samuel A Castillo; Miguel A Arenivar; Anapaula Themann; Omar Lira; Minerva Rodriguez; Joshua Preciado-Piña; Sergio D Iñiguez
Journal:  J Psychopharmacol       Date:  2018-10-18       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.